0
Reviews
Treatment of infertility in women
Carriann Smith, PharmD; Maureen Grimm, PharmD; Megan Schwegel
J Am Pharm Assoc. 2012;52:e27-e42. doi:10.1331/JAPhA.2012.12044

Abstract

Objectives  To review causes and risk factors associated with infertility, relevant diagnostic procedures, and available pharmacologic and nonpharmacologic treatment options; to identify common dosing, administration, adverse effects, and key counseling points associated with infertility treatments; and to describe the role of the pharmacist in caring for patients with infertility.

Data sources  Available clinical literature identified through searches of Medline and review of major textbooks in reproductive medicine.

Study selection  Studies were selected primarily to reflect current infertility treatment practices in the United States. The specific criteria evaluated included date of the study; date of publication; study population, including diagnosis, baseline characteristics, and nationality; and number of participants.

Data synthesis  Treatment of infertility often involves the use of both pharmacologic and nonpharmacologic therapy. This article provides an overview of these pharmacologic treatments and provides two tables that outline the key administration and safety concerns with these products. Nonpharmacologic procedures associated with diagnosis and treatment also are outlined.

Conclusion  Pharmacists are an excellent resource for patients suffering from infertility. First, pharmacists answer questions about administration and safety of these medications. Second, pharmacists discuss available treatment options and assist with referrals to specialists as needed. Third, pharmacists can provide emotional support for patients who may otherwise suffer in silence.

Sign In
APhA Members 
Welcome to JAPha.org! Please log in below using your APhA username and password. If you need to update your account information, please go to Pharmacists.org and login using your current credentials.
Username
Password


Forgot your password?
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Chandra A, Martinez GM, Mosher WD, et al. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Accessed at www.cdc.gov/nchs/data/series/sr_23/sr23_025.pdf, February 24,  2012.
 
Duwe KN, Reefhuis J, Honein MA, et al. Epidemiology of fertility treatment use among U.S. women with liveborn infants, 1997-2004.  J Womens Health. 2010;19:407–16. [CrossRef]
 
Centers for Disease Control and Prevention.  Reproductive health: infertility FAQs. Accessed at www.cdc.gov/reproductivehealth/Infertility, February 25,  2012.
 
American Pregnancy Association.  Statistics: pregnancy. Accessed at www.americanpregnancy.org/main/statistics.html, February 25,  2012.
 
Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia:  Lippincott Williams & Wilkins;  2011.
 
National Infertility Association.  Infertility diagnosis. Accessed at www.resolve.org/diagnosis-management/infertility-diagnosis, March 29,  2011.
 
Healy DL, Trounson AO, Andersen AN.  Female infertility: causes and treatment.  Lancet. 1994;343:1539–44. [CrossRef]
 
Clementini E, Palka C, Iezzi I, et al. Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques.  Hum Reprod. 2005;20:437–42. [CrossRef]
 
Maheshwari A, Hamilton M, Bhattacharya S. Effect of female age on the diagnostic categories of infertility.  Hum Reprod. 2008;23:538–42. [CrossRef]
 
Kinney A, Kline J, Kelly A, et al. Smoking, alcohol and caffeine in relation to ovarian age during the reproductive years.  Hum Reprod. 2007;22:1175–85. [CrossRef]
 
Paszkowski T, Clarke RN, Hornstein MD.  Smoking induces oxidative stress inside the Graafian follicle.  Hum Reprod. 2002;17:921–5. [CrossRef]
 
Peck JD, Leviton A, Cowan LD.  A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000–2009 update.  Food Chem Toxicol. 2010;48:2549–76. [CrossRef]
 
Grodstein F, Goldman MB, Cramer DW.  Body mass index and ovulatory infertility.  Epidemiology. 1994;5:247–50. [CrossRef]
 
Pasquali R, Gambineri A. Metabolic effects of obesity on reproduction.  Reprod Biomed Online. 2006;12:542–51. [CrossRef]
 
Green BB, Daling JR, Weiss NS, et al. Exercise as a risk factor for infertility with ovulatory dysfunction.  Am J Public Health. 1986;76:1432–6. [CrossRef]
 
National Infertility Association.  Additional testing for females. Accessed at www.resolve.org/diagnosis-management/infertility-diagnosis/additional-testing-for-females.html, January 4,  2012.
 
Jirge PR.  Ovarian reserve tests.  J Hum Reprod Sci. 2011;4:108–13. [CrossRef]
 
National Infertility Association.  Evaluating your reproductive organs. Accessed at www.resolve.org/diagnosis-management/infertility-diagnosis/evaluating-your-reproductive-organs.html, January 4,  2012.
 
Kodaman PH, Arici A, Seli E. Evidence-based diagnosis and management of tubal factor infertility.  Curr Opin Obstet Gynecol. 2004;16:221–9. [CrossRef]
 
Grimbizis GF, Tsolakidis D, Anagnostou E, et al. A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology.  Fertil Steril. 2010;94:2720–5. [CrossRef]
 
 Clomid [package insert].  Bridgewater, NJ:  Sanofi-Aventis;  2006.
 
Borglet LM, Calis KA, O'Connell MB, Smith JA. Infertility. In: Woman's health across the lifespan. Bethesda, MD: American Society of Health-System Pharmacists; 2010:339–52.
 
Holzer H, Casper R, Tulandi T. A new era in ovulation induction.  Fertil Steril. 2006;85:277–84. [CrossRef]
 
Requena A, Herrero J, Landeras J, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis.  Hum Reprod Update. 2008;14:571–82. [CrossRef]
 
Casper R. Letrozole versus climiphene citrate: which is better for ovulation induction? Fertil Steril.  2009;92:858–9.
 
Badawy A, Shokeir T, Allam AF, Abdlhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility.  Acta Obstet Gynecol. 2009;88:187–91. [CrossRef]
 
Elizur SE, Tulandi T. Drugs in infertility and fetal safety.  Fertil Steril. 2008;89:1595–602. [CrossRef]
 
Kiesel LA, Rody A, Greb RR, Szilagy A. Clinical use of GnRH analogues.  Clin Endocrinol (Oxf). 2002;56:677–87. [CrossRef]
 
Humaidan P, Quartarolo J, Papanikalaou EG.  Preventing ovarian hyperstimulation syndrome: guidance for the clinician.  Fertil Steril. 2010;94:389–400. [CrossRef]
 
Follistim AQ (follitropin beta injection) [package insert].  Whitehouse Station, NJ:  Schering-Plough;  2010.
 
Gonal F (follitropin alfa for injection) [package insert].  Rockland, MA:  EMD Serono;  2009.
 
 Bravelle (urofollitropin for injection) [package insert].  Parsippany, NJ:  Ferring;  2008.
 
Rombauts L, Talmor A. Corifollitropin alfa for female infertility.  Expert Opin Biol Ther. 2012;12:107–12. [CrossRef]
 
de Lartigue J. Corifollitropin alfa: a new option to treat female infertility.  Drugs Today (Barc). 2011;47:583–90.
 
Shoham Z, Smith H, Yeko T, et al. Recombinant LH (lutropin alfa) for the treatment of hypogonadotropic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study.  Clin Endocrinol. 2008;69:471–8. [CrossRef]
 
 Menopur (menotropins for injection) [package insert].  Tarrytown, NJ:  Ferring;  2010.
 
 Repronex (menotropins for injection) [package insert].  Tarrytown, NJ:  Ferring;  2001.
 
Coomarasamy A, Afnan M, Cheema D, et al. Urinary hMG versus recombinant FSH for COH following an agonist long down-regulatory protocol in IVF or ICSI treatment: a systematic review and meta-analysis.  Hum Reprod. 2008;23:310–5. [CrossRef]
 
Al-Inany HG, Abou-setta AM, Aboulghar MA, et al. Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis.  Gynecol Endocrinol. 2009;25:372–8. [CrossRef]
 
Lehert P, Schertz JC, Ezcurra D. Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis.  Reprod Biol Endocrinol. 2010;8:112. [CrossRef]
 
 Ovidrel (choriogonadotropin alfa injection) [package insert].  Rockland, MA:  EMD Serono;  2010.
 
Devroey P, Abyholm T, Diedrich K, et al. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotropin releasing hormone antagonist ganirelix to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone.  Human Reprod. 1998;13:3023–31. [CrossRef]
 
Bakas P, Konidaris S, Liapis A, et al. Role of gonadotropin-releasing hormone antagonist in the management of subfertile couples with intrauterine insemination and controlled ovarian stimulation.  Fertil Steril. 2011;95:2024–8. [CrossRef]
 
Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.  N Engl J Med. 1998;338:1876–80. [CrossRef]
 
Nestler JE.  Metformin for the treatment of the polycystic ovary syndrome.  N Engl J Med. 2008;358:47–54. [CrossRef]
 
 Parlodel [package insert].  Suffern, NY:  Novartis;  2006.
 
Xue T, Li SW, Wang Y. Effectiveness of bromocriptine monotherapy or combination treatment with clomiphene for infertility in women with galactorrhea and normal prolactin: a systematic review and meta-analysis.  Curr Ther Res Clin Exp. 2010;71(4):199–210. [CrossRef]
 
Kleinstein J,  Luteal Phase Study Group. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.  Fertil Steril. 2005;83:1641–9. [CrossRef]
 
Mitwally MF, Diamond MP, Abuzeid M. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.  Fertil Steril. 2010;93:554–69. [CrossRef]
 
 Prometrium [package insert]. North Chicago, IL:  Abbott;  2011.
 
Hsieh YY, Tsai HD, Chang CC, et al. Low-dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: a prospective, randomized study.  J Assist Reprod Genet. 2000;17(3):174–7. [CrossRef]
 
National Infertility Association.  Donor options. Accessed at www.resolve.org/family-building-options/donor-options/donor-options.html, January 4,  2012.
 
Schering-Plough.  GfK National survey complete results. Accessed at www.planforsomeday.com/survey.aspx, February 24,  2012.
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration.
The Journal of clinical investigation: Issue date- 2012 Oct 1
Reproductive technologies and the risk of birth defects.
The New England journal of medicine: Issue date- 2012 May 10
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints